Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022;66:15–23.

Article  PubMed  PubMed Central  Google Scholar 

National Cancer Center Japan, Center for Cancer Control and Information Services https://ganjoho.jp/reg_stat/statistics/stat/summary.html

Bonadonna G, Valagussa P, Brambilla C, Ferrari LG. Preoperative chemotherapy in operable breast cancer. Lancet. 1993;341:1485.

Article  CAS  PubMed  Google Scholar 

Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan MM, et al. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 2021;32:1216–35.

Article  CAS  PubMed  Google Scholar 

Agostinetto E, Gligorov J, Piccart M. Systemic therapy for early-stage breast cancer: learning from the past to build the future Nat Rev. Clin Oncol. 2022;19:763–74.

CAS  Google Scholar 

von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, et al. Trastuzumab Emtansine for residual invasive HER2-positive breast cancer. N Engl J Med. 2019;380:617–28.

Article  Google Scholar 

Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, et al. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376:2147–59.

Article  CAS  PubMed  Google Scholar 

Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, et al. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer. Ann Oncol. 2022;33:1250–68.

Article  CAS  PubMed  Google Scholar 

Johnston SRD, Toi M, O’Shaughnessy J, Rastogi P, Campone M, Neven P, et al. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial. Lancet Oncol. 2023;24:77–90.

Article  CAS  PubMed  Google Scholar 

Toi M, Imoto S, Ishida T, Ito Y, Iwata H, Masuda N, et al. Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021;22:74–84.

Article  CAS  PubMed  Google Scholar 

Al-Ghazal SK, Sully L, Fallowfield L, Blamey RW. The psychological impact of immediate rather than delayed breast reconstruction. Eur J Surg Oncol. 2000;26:17.

Article  CAS  PubMed  Google Scholar 

Atisha D, Alderman AK, Lowery JC, Kuhn LE, Davis J, Wikins EG. Prospective analysis of long-term psychosocial outcomes in breast reconstruction: two-year postoperative results from the Michigan breast reconstruction outcomes study. Ann Surg. 2008;247:1019–28.

Article  PubMed  Google Scholar 

Retrouvey H, Kerrebijn I, Metcalfe KA, O’Neill AC, McCready DR, Hofer SOP, et al. Psychosocial functioning in women with early breast cancer treated with breast surgery with or without immediate breast reconstruction. Ann Sur Oncol. 2019;26:2444–51.

Article  Google Scholar 

Wu ZY, Kim HJ, Lee JW, Chung IY, Kim JS, Lee SB, et al. Long-term oncologic outcomes of immediate breast reconstruction vs conventional mastectomy alone for breast cancer in the setting of neoadjuvant chemotherapy. JAMA Surg. 2020;155:1142–50.

Article  PubMed  PubMed Central  Google Scholar 

Retrouvey H, Solaja O, Gagliardi AR, Webster F, Zhong T. Barriers of access to breast reconstruction: a systematic review. Plast Reconstr Surg. 2019;143:465e–76e.

Article  CAS  PubMed  Google Scholar 

Yamakado R, Ishitobi M, Kondo N, Yamauchi C, Sasada S, Nogi H, et al. Physicians’ perception about the impact of breast reconstruction on patient prognosis: a survey in Japan. Breast Cancer. 2023;30:302–8.

Article  PubMed  Google Scholar 

Mitchem J, Herrmann D, Margenthaler JA, Aft RL. Impact of neoadjuvant chemotherapy on rate of tissue expander/implant loss and progression to successful breast reconstruction following mastectomy. Am J Surg. 2008;196:519–22.

Article  CAS  PubMed  Google Scholar 

Dolen UC, Schmidt AC, Um GT, Sharma K, Naugton M, Zoberi I, et al. Impact of neoadjuvant and adjuvant chemotherapy on immediate tissue expander breast reconstruction. Ann Surg Oncol. 2016;23:2357–66.

Article  PubMed  Google Scholar 

Eriksson M, Anveden L, Celebioglu F, Dahlberg K, Meldahl I, Lagergren J, et al. Radiotherapy in implant-based immediate breast reconstruction: risk factors, surgical outcomes, and patient-reported outcome measures in a large Swedish multicenter cohort. Breast Cancer Res Treat. 2013;142:591–601.

Article  PubMed  Google Scholar 

Cordeiro PG, Albornoz CR, McCormick B, Hu Q, Van Zee K. The impact of postmastectomy radiotherapy on two-stage implant breast reconstruction: an analysis of long-term surgical outcomes, aesthetic results, and satisfaction over 13 years. Plast Reconstr Surg. 2014;134:588–95.

Article  CAS  PubMed  Google Scholar 

Varghese J, Gohari SS, Rizki H, et al. A systematic review and meta-analysis on the effect of neoadjuvant chemotherapy on complications following immediate breast reconstruction. Breast. 2021;55:55–62.

Article  PubMed  Google Scholar 

Lorentzen T, Heidemann LN, Möller S, Bille C. Impact of neoadjuvant chemotherapy on surgical complications in breast cancer: a systematic review and meta-analysis. Eur J Surg Oncol. 2022;48:44–52.

Article  PubMed  Google Scholar 

Donker M, Hage JJ, Woerdeman LA, Rutgers EJ, Sonke GS, Peeters MJ. Surgical complications of skin sparing mastectomy and immediate prosthetic reconstruction after neoadjuvant chemotherapy for invasive breast cancer. Eur J Surg Oncol. 2012;38:25–30.

Article  CAS  PubMed  Google Scholar 

Abt NB, Flores JM, Baltodano PA, Sarhane KA, Abreu FM, Cooney CM, et al. Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction. JAMA Surg. 2014;149:1068–76.

Article  PubMed  PubMed Central  Google Scholar 

Teotia SS, Venutolo C, Haddock NT. Outcomes in patients receiving neoadjuvant chemotherapy undergoing immediate breast reconstruction: effect of timing, postoperative complications, and delay to radiation therapy. Plast Reconstr Surg. 2019;144:732e-e742.

Article  CAS  PubMed  Google Scholar 

Riba J, de Romani SE, Masia J. Neoadjuvant chemotherapy for breast cancer treatment and the evidence-based interaction with immediate autologous and implant-based breast reconstruction. Clin Plast Surg. 2018;45:25–31.

Article  PubMed  Google Scholar 

Ryu JM, Park S, Paik HJ, Nam SJ, Kim SW, Lee SK, et al. Oncologic safety of immediate breast reconstruction in breast cancer patients who underwent neoadjuvant chemotherapy: short-term outcomes of a matched case-control study. Clin Breast Cancer. 2017;17:204–10.

Article  PubMed  Google Scholar 

Wengler CA, Valente SA, Al-Hilli Z, Woody NM, Muntean JH, Abraham J, et al. Determinants of short and long term outcomes in patients undergoing immediate breast reconstruction following neoadjuvant chemotherapy. J Surg Oncol. 2017;116:797–802.

Article  CAS  PubMed  Google Scholar 

Inokuchi M, Kutomi G, Kijima Y, Sakai T, Sawaki M, Shien T, et al. The Japanese Breast Cancer Society clinical practice guidelines for surgical treatment of breast cancer, 2018 edition. Breast Cancer. 2020;27:4–8.

Article  PubMed  Google Scholar 

National Comprehensive Cancer Network: NCCN guidelines. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed 1 June 2023.

Haffty BG, McCall LM, Ballman KV, McLaughlin S, Jagsi R, Ollila DW, et al. Patterns of local-regional management following neoadjuvant chemotherapy in breast cancer: results from ACOSOG Z1071 (Alliance). Int J Radiat Oncol Biol Phys. 2016;94:493–502.

Article  PubMed  Google Scholar 

Hoffman KE, Mittendorf EA, Buchholz TA. Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy. Lancet Oncol. 2012;13:e270–6.

Article  PubMed  Google Scholar